Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-20T05:08:07.958Z Has data issue: false hasContentIssue false
  • English
  • Français

P0159 - Metabolic syndrome in patients with bipolar disorder

Published online by Cambridge University Press:  16 April 2020

B. Vuksan-Cusa ,
S. Nadj ,
D. Marcinko ,
M. Jakovljevic  and
R. Topic
B. Vuksan-Cusa
Affiliation:
University Hospital Centre, Psychiatric Clinic, Zagreb, Croatia General Hospital, Virovitica, Croatia
S. Nadj
Affiliation:
University Hospital Centre, Psychiatric Clinic, Zagreb, Croatia General Hospital, Virovitica, Croatia
D. Marcinko
Affiliation:
University Hospital Centre, Psychiatric Clinic, Zagreb, Croatia General Hospital, Virovitica, Croatia
M. Jakovljevic
Affiliation:
University Hospital Centre, Psychiatric Clinic, Zagreb, Croatia General Hospital, Virovitica, Croatia
R. Topic
Affiliation:
University Hospital Centre, Psychiatric Clinic, Zagreb, Croatia General Hospital, Virovitica, Croatia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Previous studies on the prevalence of metabolic syndrome in patients with bipolar disorder have reported higher rates than in their respective general populations.

Objective:

This study evaluates the prevalence rate and modal subcomponents of metabolic syndrome in 34 patients treated in University Hospital Centre Zagreb,Croatia.

Method:

Naturalistic, cross sectional study. Patients were evaluated for the presence of metabolic syndrome according to NCEP ATP-III criteria.

Results:

Mean age was 41.1(SD 12.9). Overall prevalence rate of MetS was 35.3%. Forty seven percent met the criterion for abdominal obesity, 58.8% for hypertrigliceridemia, 23.5 % for low HDL cholesterol, 50.0% for hypertension, and 23.5 for high fasting glucose. There was no diference in the prevalence rate by gender.

Conclusions:

Clinical medical monitoring for these parameters is recommended. Psychotropic drugs use may confer differential risk for developing the metabolic syndrome.

Type
Poster Session II: Bipolar Disorders
Information
European Psychiatry , Volume 23 , Issue S2: 16th AEP Congress - Abstract book - 16th AEP Congress , April 2008 , pp. S238 - S239
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.